FOS and B-cell chronic lymphocytic leukemia: Remarkably, the comparison of AP‐1 complex inhibition in the two co‐culture regions revealed a significantly reduced survival rate of CLL cells exposed to SR/T5 alone or in combination with Enzastaurin in the core region.